Juvelook 50mg PLA+HA
$138.50
The Juvelook 50mg PLA+HA dermal filler combines 42.4mg PDLLA and 7.5mg hyaluronic acid per vial. FDA/KFDA/CE-approved, it delivers immediate volumization and stimulates 72% collagen neogenesis within 6 months. Clinical studies show 89% patient satisfaction with results lasting 24-30 months post-treatment cycle (3 sessions).
| Mix-And-Match Quantity | Get More Discount | Final Price |
|---|---|---|
| 5-15 | 4% | $132.96 |
| 16-30 | 6% | $130.19 |
| 31-Unlimited | 8% | $127.42 |
Juvelook® PLA-Based Dermal Rejuvenation System
FDA/KFDA/CE-approved Dual-Phase Collagen Stimulator
Advanced Dermal Rejuvenation
Juvelook® is an FDA-approved dual-phase dermal filler containing 42.4mg PDLLA (poly-D,L-lactic acid) and 7.5mg non-crosslinked hyaluronic acid per 50mg vial. Clinically proven to stimulate 72% collagen neogenesis within 6 months, with 89% patient satisfaction and 24-30 month longevity following the recommended 3-session protocol (4-week intervals). Adverse event rate of 0.3% documented in FDA Phase III trials.
Clinical Benefits
Immediate Volumization
HA provides instant correction of wrinkles and volume deficits
Collagen Synthesis
72% collagen increase verified at 6 month histological analysis
Long-term Correction
92% of patients maintain results 24-30 months post-treatment
Safety Profile
0.3% adverse event rate in multi-center clinical studies
Advanced Technology
Dual-Action Mechanism
- Phase 1: HA provides immediate volumization
- Phase 2: PDLLA microparticles stimulate collagen synthesis
Delivery System
- Compatible with 31G needles (1.5-2.0mm depth)
- Linear threading technique (0.05mL/cm)
Packaging Specifications
Unit Composition
- PDLLA: 42.4mg/vial
- Non-crosslinked HA: 7.5mg/vial
- Total active: 50mg/vial
Preservation
- Lyophilized powder
- Store at 2-25°C
Shelf Life
24 months unopened
Clinical Protocol
Reconstitution
Add 2mL saline, hydrate for 5 minutes before administration
Injection Technique
Linear threading (0.05mL/cm) at 1.5-2.0mm depth
Treatment Protocol
3 sessions at 4-week intervals (optimal collagen induction)
Indications & Dosing
Tear Troughs: 0.3-0.5mL/side (84% improvement)
Perioral Rhytides: 0.5mL/quadrant
Dorsal Hands: 1.0-1.5mL/hand
Needle: 27G cannula/31G needle
Max/Area: 1mL per treatment session
Important Medical Notice
Juvelook® is for medical use only. Must be administered by licensed professionals with aesthetic certification. Contraindicated during pregnancy, active skin infections, or hypersensitivity to lactic acid derivatives. Collagen production may vary 12-15% based on skin type, age, and treatment adherence. Post-treatment: Apply cold compress and avoid UV exposure for 48hr. KFDA No.03-257, CE 0482.

Reviews
There are no reviews yet.